Effect of an Analgo-sedation Protocol for Patients With Spontaneous Intracerebral Hemorrhage

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

This study evaluates the safety and efficacy of an analog-sedation protocol for patients with mild to moderate brain injuries in intensive care unit. Patients are randomly divided into two groups. The Analgesia-based sedation group will receive remifentanil before the addition of a sedative(Dexmedetomidine). The conventional-based sedation group will be sedated as usual(non-protocolized). Furthermoreļ¼Œpatients in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 July 2017.

1 Aug 2017 26 Jun 2017 1 Aug 2021 1 Aug 2021 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts